PRODUCT LITERATURE

Nebivolol for the Treatment of Essential Systemic Arterial Hypertension: A Systematic Review and Meta‑Analysis

---

Cardiovascular diseases are the main cause of mortality worldwide, and systemic arterial hypertension is associated with a large number of these cases. The objective of health professionals and health policies should be searching for the best therapeutics to control this disease. A recent consensus indicated that β-blockers have recently lost their place in initial indications for the treatment of systemic arterial hypertension and are now more indicated for the treatment of hypertension in association with other clinical situations such as angina, heart failure and arrhythmia; however, it is known that this approach was based on studies that evaluated older β-blockers such as atenolol

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Nevodio
Nebivolol
Cardiovascular diseases

Specific Detail Info

American Journal of Cardiovascular Drugs (2021) 21:165–180

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment